Filament Health Corp. (FH.NE)

0.0500 0.0000 (0.00%) At close: 03:09PM EDT

Filament Health Corp.

4475 Wayburne Drive
Unit 210
Burnaby, BC V5G 4X4
Canada

https://filament.health

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full Time Employees: 13

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Benjamin Lightburn	Co-Founder, CEO & Chairman	175k	N/A	1986
Andry Tjahyana	VP of Business Development	190k	N/A	N/A
Mr. Jonathan Conlin	Corporate Secretary & Director	N/A	N/A	1985
Mr. Steven Nguyen CPA	Interim Chief Financial Officer	N/A	N/A	N/A
Ms. Lisa Ranken	Chief Operating Officer	N/A	N/A	1984
Mr. Ryan Moss	Chief Science Officer	N/A	N/A	N/A
Ms. Anna Cordon	Vice President of Marketing & Communications	N/A	N/A	N/A
Mr. Jeff Fellows	Head of Regulatory	N/A	N/A	N/A

Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

Filament Health Corp. operates as a clinical-stage natural psychedelic drug development company. The company propagates psychedelic plants and fungi; conducts genetic research; develops manufacturing technology; generates intellectual property; conducts in-house trials; and distributes drug candidates to drug developers, researchers, and other licensed parties. Filament Health Corp. is headquartered in Burnaby, Canada.

Corporate Governance

Filament Health Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.